Abstract:Background: In recent years, tissue engineered bone by gene-modified stem cells compounded with scaffold materials in repair of bone defect has provided a novel thought for the bone tissue reconstruction. Objective: To explore the effect on repairing mandibular defect with human bone morphogenetic protein-2 (hBMP-2) gene transfected bone marrow mesenchymal stem cells (BMSCs) compounded with coral hydroxyapatite (CHA) scaffolds in osteoporotic rats. Design, time and setting: A randomized control animal experiment was completed at the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education from June 2005 to October 2006. Materials: Twenty-four unpregnant female Sprague-Dawley rats, 6 months old, SPF gradem weighing 250-300 g, were used to establish models of postmenopausal osteoporosis, The pcDNA3.1-hBMP-2 recombinant plasmid carrying hBMP-2 was offered by the Third Military Medical University of Chinese PLA; CHA scaffolds was offered by the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education. Methods: Twenty-four SD rats were divided into experimental group and control group at random, each containing 12 animals. Three months later, BMSCs harvested from osteoporotic rats were transfected by pcDNA3.1-hBMP-2 recombinant plasmid, and control group leaved untreated. Three days later, the transfected and untransfected autogenous BMSCs were seeded into CHA scaffolds, respectively. Then the cell/scaffolds composites were implanted into the critical-size defect area in the mandible bone of osteoporotic rats. Main outcome measures: At the 4th and 8th weeks after implantation, immunohistochemical analysis was performed to evaluate the new bone formation, and the amount of newly formed bone was detected semi-quantitatively at the 8th weeks. Results: All 24 SD rats were involved in the result analysis. 1 Newly formed bone was found at the margin of the defect area treated with the BMSCs modified by BMP-2 gene transfer at 4 weeks after implantation. The lamellar bone matrix was visible at 8 weeks. In the control group, only a little bone matrix was observed at the margin of CHA material at 4 weeks after implantation, however, the amount of newly formed bone was much less than the experimental group, and there was some adipose-like tissues at defect margins and central part at 8 weeks after implantation. 2 The percentage of newly formed bone area was (0.046±0.004)% and (0.233±0.015)% in the control group and the experimental group, respectively. There were significant differences in the amount of newly formed bone between two groups (P < 0.01). Conclusion: Tissue engineered bone formed by hBMP-2 gene-modified BMSCs in conjunction with CHA scaffolds, can allow large bone formation for treatment of mandibular defect in osteoporosis rats.

The effects of nano-chitosan/bone morphogenetic protein gel on the repair of mandibular defect

Histological examination of activated nano-hydroxyapatite/collagen in repairing mandibular defects

Repair of Mandibular Defects with Hydrogel Loaded with Nano-Hydroxyapatite in Rats

Experimental study of Nerve growth factormixed with the Scaffold materials repair rabbit mandible

Experimental studies regarding injectable chitosan/β-TCP/rhBMP-2 composite in repairing rabbit mandible defects

Effects of a bone graft substitute consisting of porous gradient HA/ZrO 2 and gelatin/chitosan slow-release hydrogel containing BMP-2 and BMSCs on lumbar vertebral defect repair in rhesus monkey.

Simvastatin Nano Hydroxyapatite Scaffold on the Restoration of Mandible Defect

Compound bone morphogenetic protein-alpha-cyanoacrylate biological glue repairs mandibular defects in rats

Injectable nano/chitosan/bone morphogenetic protein-2 induces periodontal tissue regeneration

Degradable release and osteogenesis of recombinant human bone morphogenetic protein 2 system with water-soluble chitosan

Nano-chitosan/bone morphogenetic protein gel prevents absorption of rat’s alveolar ridge

The Ability and Mechanism of nHAC/CGF in Promoting Osteogenesis and Repairing Mandibular Defects

Repair of Rat Cranial Bone Defect by Using Bone Morphogenetic Protein-2-related Peptide Combined with Microspheres Composed of Polylactic Acid/polyglycolic Acid Copolymer and Chitosan

Biphasic calcium phosphate nanocomposite loaded with bone marrow stromal cells for repair of critical cranial defect in rats

Bone morphogenetic protein-2 sustained delivery by hydrogels with microspheres repairs rabbit mandibular defects

Experimental Study on Advanced Bone Regeneration by BMP-7 Derived-Peptide Chitosan Nanometer Hydroxyapatite Collagen Biomimetic Composite

Dual delivery of BMP-2 and bFGF from a new nano-composite scaffold, loaded with vascular stents for large-size mandibular defect regeneration

Vascularization and Bone Regeneration in a Critical Sized Defect Using 2-N,6-o-sulfated Chitosan Nanoparticles Incorporating BMP-2.

Repairing mandibular defect by gene-modified bone marrow mesenchymal stem cells combined with coral hydroxyapatite scaffold in osteoporotic rats

Application of nano-collagen basal bone in repairing bone defects of periapical and periodontal diseases

The Experimental Study of Periodontal Bone Defects Repair with Bone Morphogenetic Protein-Nano-hap-collagen